p53 biomarker News
Most Popular p53 biomarker Story
Introgen files first gene therapy for FDA approval
After 14 years of research, Introgen Therapeutics is asking the FDA to give its BLA for a gene-based therapy for head and neck cancer - Advexin -- a priority review. Experts in the field told the... Read more...
Latest Headlines
- September 2, 2008
- April 15, 2008
- September 27, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
